<div class="at-above-post addthis tool" data-url="https://www.metro.us/norway-ready-for-reduced/"></div>OSLO (Reuters) – Norway anticipates reduced supply of the Pfizer/BioNTech vaccine until the second week of February, but has an emergency stockpile and will continue administering doses as planned, the government’s public health body said. Pfizer said last week it would until early February reduce deliveries to Europe of the shots developed with its partner […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www.metro.us/norway-ready-for-reduced/&quo
Norway anticipates reduced supply of the Pfizer/BioNTech vaccine until the second week of February, but has an emergency stockpile and will continue administering doses as planned, the government's public health body said.
Newsbook
January 21, 2021 4:57 PM
Malta received fewer doses of the Pfizer-BioNTech vaccine than expected, Deputy Prime Minister and Health Minister Chris Fearne told reporters on Thursday.
To date only Pfizer and Moderna’s coronavirus vaccines have been approved by the European regulator, the European Medicines Agency.
Last week, the Norwegian Institute of Public Health said Pfizer will temporarily reduce its deliveries to Europe citing an upgrade in the manufacturing plant as a reason behind the delay.
Newsbook.com.mt sent questions to the health ministry to inquire how this decision will be affecting Malta last week. The questions remained unanswered.
Fielding questions from reporters on Thursday, Fearne explained that this week all EU member states received less doses than expected from the US manufacturer.